FoRx Therapeutics

About FoRx Therapeutics

FoRx Therapeutics is a privately-held company based in Basel, Switzerland, focused on developing first-in-class compounds for cancer treatment. The company targets key molecular components involved in DNA replication stress to create innovative, targeted anticancer drugs.

Products & Services

First-in-class compounds:Compounds targeting molecular components involved in DNA replication stress for cancer treatment.

Specialties

DNA replication stress DNA Damage Response pathways Cancer biology Cancer genomics Biochemistry Medicinal chemistry Small molecule drug discovery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 50000000 MR: - FA: USD 50 million FAN: 50000000	D: 2025-12-18 FD: 2025-12-18	4 investors

Series A Latest

2025-12-18

$50.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Thanos Halazonetis

DDS, PhD - Observer

S

Sotirios K. Sotiriou

Molecular Cancer Biologist

T

Timothy Yap

Medical Oncologist and Physician-Scientist

C

Christopher Lord

Deputy Head of Division and Group Leader

J

John Todd

R

Richard Gardner

View 17 more team members with Pro

Unlock Full Team Directory

Recent News